1. Home
  2. OPEN vs FTRE Comparison

OPEN vs FTRE Comparison

Compare OPEN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opendoor Technologies Inc

OPEN

Opendoor Technologies Inc

HOLD

Current Price

$2.00

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$23.78

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPEN
FTRE
Founded
2014
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
OPEN
FTRE
Price
$2.00
$23.78
Analyst Decision
Hold
Buy
Analyst Count
9
13
Target Price
$4.27
★ $21.46
AVG Volume (30 Days)
★ 28.5M
1.5M
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $4,371,000,000.00
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$90.27
$3.30
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 1.00
52 Week Low
$1.93
$8.55
52 Week High
$9.44
$24.36

Technical Indicators

Market Signals
Indicator
OPEN
FTRE
Relative Strength Index (RSI) 31.90 70.32
Support Level N/A $15.94
Resistance Level $2.81 N/A
Average True Range (ATR) 0.16 1.28
MACD 0.01 0.25
Stochastic Oscillator 15.45 75.37

Price Performance

Historical Comparison
OPEN
FTRE

About OPEN Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: